Head to Head Review: Mazor Robotics (MZOR) vs. Varian Medical Systems (VAR)
Mazor Robotics (NASDAQ: MZOR) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.
Volatility & Risk
Mazor Robotics has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.
This is a breakdown of current recommendations for Mazor Robotics and Varian Medical Systems, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Varian Medical Systems||2||7||1||0||1.90|
Mazor Robotics presently has a consensus price target of $39.60, suggesting a potential downside of 25.34%. Varian Medical Systems has a consensus price target of $98.39, suggesting a potential downside of 12.14%. Given Varian Medical Systems’ stronger consensus rating and higher probable upside, analysts clearly believe Varian Medical Systems is more favorable than Mazor Robotics.
This table compares Mazor Robotics and Varian Medical Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Varian Medical Systems||8.85%||23.68%||10.74%|
Insider and Institutional Ownership
26.5% of Mazor Robotics shares are held by institutional investors. Comparatively, 99.2% of Varian Medical Systems shares are held by institutional investors. 0.9% of Varian Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Mazor Robotics and Varian Medical Systems’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Mazor Robotics||$36.38 million||37.21||-$18.66 million||($0.71)||-74.70|
|Varian Medical Systems||$2.67 billion||3.85||$249.60 million||$2.69||41.63|
Varian Medical Systems has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Varian Medical Systems, indicating that it is currently the more affordable of the two stocks.
Varian Medical Systems beats Mazor Robotics on 10 of the 12 factors compared between the two stocks.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.
About Varian Medical Systems
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.